We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$15.4B
AUM Growth
+$3.25B
(+27%)
Cap. Flow
+$3.84B
Cap. Flow
% of AUM
24.9%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$246M |
| 2 |
Microsoft
MSFT
|
+$216M |
| 3 |
Amazon
AMZN
|
+$130M |
| 4 |
Tesla
TSLA
|
+$79.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$73.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$49.3M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$11.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$11.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.56M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 12.21% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRBK
2576
DELISTED
Republic First Bancorp Inc
FRBK
| $126K | ﹤0.01% |
+24,505
| New | +$118K |
|
2577
The ONE Group
STKS
$56.5M
| $126K | ﹤0.01% |
12,015
+4,326
| +56% | +$50.8K |
|
|
VRS
2578
DELISTED
Verso Corporation
VRS
| $126K | ﹤0.01% |
4,675
-3,209
| -41% | -$85.8K |
|
2579
Madison Square Garden
MSGS
$9.97B
| $126K | ﹤0.01% |
+700
| New | +$119K |
|
2580
American Superconductor
AMSC
$1.56B
| $125K | ﹤0.01% |
16,405
+5,575
| +51% | +$47.7K |
|
2581
Teekay
TK
$1.03B
| $124K | ﹤0.01% |
+39,120
| New | +$127K |
|
|
AZEK
2582
DELISTED
The AZEK Co
AZEK
| $124K | ﹤0.01% |
+4,992
| New | +$157K |
|
2583
FS Bancorp
FSBW
$325M
| $124K | ﹤0.01% |
3,991
+1,439
| +56% | +$46.8K |
|
2584
First Bank
FRBA
$469M
| $123K | ﹤0.01% |
8,675
+3,093
| +55% | +$44.4K |
|
2585
Cogent Biosciences
COGT
$6.76B
| $123K | ﹤0.01% |
16,460
+12,193
| +286% | +$84.9K |
|
2586
Ezcorp Inc
EZPW
$1.78B
| $122K | ﹤0.01% |
20,201
+13,919
| +222% | +$86.8K |
|
|
KLRS
2587
Kalaris Therapeutics
KLRS
$93.8M
| $122K | ﹤0.01% |
785
+267
| +52% | +$53.3K |
|
|
GHL
2588
DELISTED
Greenhill & Co., Inc.
GHL
| $122K | ﹤0.01% |
7,855
+2,886
| +58% | +$50.6K |
|
|
CMBM
2589
DELISTED
Cambium Networks
CMBM
| $121K | ﹤0.01% |
5,138
+1,896
| +58% | +$45.9K |
|
|
GATO
2590
DELISTED
Gatos Silver, Inc.
GATO
| $121K | ﹤0.01% |
28,113
+10,206
| +57% | +$56.2K |
|
2591
Brown-Forman Class A
BF.A
$13B
| $120K | ﹤0.01% |
+1,919
| New | +$119K |
|
2592
Ribbon Communications
RBBN
$372M
| $120K | ﹤0.01% |
38,902
+26,999
| +227% | +$111K |
|
2593
Apyx Medical
APYX
$126M
| $120K | ﹤0.01% |
18,314
+6,649
| +57% | +$65.5K |
|
2594
Westlake Corp
WLK
$10.1B
| $118K | ﹤0.01% |
+958
| New | +$104K |
|
2595
Arbutus Biopharma
ABUS
$908M
| $118K | ﹤0.01% |
39,628
+29,648
| +297% | +$90.8K |
|
2596
Inseego
INSG
$82.6M
| $118K | ﹤0.01% |
2,912
-65
| -2% | -$2.97K |
|
2597
Matrix Service
MTRX
$330M
| $116K | ﹤0.01% |
+14,152
| New | +$107K |
|
2598
SiriusXM
SIRI
$9.59B
| $115K | ﹤0.01% |
+1,739
| New | +$109K |
|
2599
Opendoor
OPEN
$3.39B
| $114K | ﹤0.01% |
+13,648
| New | +$127K |
|
2600
Ocular Therapeutix
OCUL
$2.25B
| $113K | ﹤0.01% |
22,914
-5,491
| -19% | -$30.4K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.
- MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
- MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
- MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
- MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
- MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
- MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
- MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.